In conclusion, targeted down-regulation of the DNM1L/DRP1-FIS1 axis in glioma can regulate mitophagy and impact the remodeling and OXPHOS function of MRC, ultimately inhibiting tumor occurrence and progression (Fig. 11). Here, CD200 is linked to glioma.